200 related articles for article (PubMed ID: 20437463)
1. Involvement of an influx transporter in the blood-brain barrier transport of naloxone.
Suzuki T; Ohmuro A; Miyata M; Furuishi T; Hidaka S; Kugawa F; Fukami T; Tomono K
Biopharm Drug Dispos; 2010 May; 31(4):243-52. PubMed ID: 20437463
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier transport of naloxone does not involve P-glycoprotein-mediated efflux.
Suzuki T; Miyata M; Zaima C; Furuishi T; Fukami T; Kugawa F; Tomono K
J Pharm Sci; 2010 Jan; 99(1):413-21. PubMed ID: 19530072
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
[TBL] [Abstract][Full Text] [Related]
4. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.
Isakovic AJ; Abbott NJ; Redzic ZB
J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584
[TBL] [Abstract][Full Text] [Related]
5. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier.
Deguchi T; Isozaki K; Yousuke K; Terasaki T; Otagiri M
J Neurochem; 2006 Feb; 96(4):1051-9. PubMed ID: 16445853
[TBL] [Abstract][Full Text] [Related]
6. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier.
Ishiguro N; Nozawa T; Tsujihata A; Saito A; Kishimoto W; Yokoyama K; Yotsumoto T; Sakai K; Igarashi T; Tamai I
Drug Metab Dispos; 2004 May; 32(5):519-24. PubMed ID: 15100174
[TBL] [Abstract][Full Text] [Related]
7. Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier.
Kikuchi R; Kusuhara H; Sugiyama D; Sugiyama Y
J Pharmacol Exp Ther; 2003 Jul; 306(1):51-8. PubMed ID: 12684544
[TBL] [Abstract][Full Text] [Related]
8. In vivo evidence for carrier-mediated uptake of beta-lactam antibiotics through organic anion transport systems in rat kidney and liver.
Tsuji A; Terasaki T; Tamai I; Takeda K
J Pharmacol Exp Ther; 1990 Apr; 253(1):315-20. PubMed ID: 2329514
[TBL] [Abstract][Full Text] [Related]
9. Blood-to-brain influx transport of nicotine at the rat blood-brain barrier: involvement of a pyrilamine-sensitive organic cation transport process.
Tega Y; Akanuma S; Kubo Y; Terasaki T; Hosoya K
Neurochem Int; 2013 Jan; 62(2):173-81. PubMed ID: 23228345
[TBL] [Abstract][Full Text] [Related]
10. The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-alpha.
Lee NY; Kang YS
Brain Res; 2004 Oct; 1023(1):141-7. PubMed ID: 15364029
[TBL] [Abstract][Full Text] [Related]
11. Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: in vivo evidence by use of the brain efflux index method.
Kakee A; Terasaki T; Sugiyama Y
J Pharmacol Exp Ther; 1997 Dec; 283(3):1018-25. PubMed ID: 9399971
[TBL] [Abstract][Full Text] [Related]
12. Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs.
Mori S; Ohtsuki S; Takanaga H; Kikkawa T; Kang YS; Terasaki T
J Neurochem; 2004 Aug; 90(4):931-41. PubMed ID: 15287899
[TBL] [Abstract][Full Text] [Related]
13. Investigation on the influx transport mechanism of pentazocine at the blood-brain barrier in rats using the carotid injection technique.
Suzuki T; Moriki Y; Goto H; Tomono K; Hanano M; Watanabe J
Biol Pharm Bull; 2002 Oct; 25(10):1351-5. PubMed ID: 12392093
[TBL] [Abstract][Full Text] [Related]
14. Investigation of transport mechanism of pentazocine across the blood-brain barrier using the in situ rat brain perfusion technique.
Suzuki T; Oshimi M; Tomono K; Hanano M; Watanabe J
J Pharm Sci; 2002 Nov; 91(11):2346-53. PubMed ID: 12379919
[TBL] [Abstract][Full Text] [Related]
15. Involvement of multiple transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors across the blood-brain barrier.
Kikuchi R; Kusuhara H; Abe T; Endou H; Sugiyama Y
J Pharmacol Exp Ther; 2004 Dec; 311(3):1147-53. PubMed ID: 15292460
[TBL] [Abstract][Full Text] [Related]
16. Impact of capillary flow hydrodynamics on carrier-mediated transport of opioid derivatives at the blood-brain barrier, based on pH-dependent Michaelis-Menten and Crone-Renkin analyses.
Yusof SR; Abbott NJ; Avdeef A
Eur J Pharm Sci; 2017 Aug; 106():274-286. PubMed ID: 28614733
[TBL] [Abstract][Full Text] [Related]
17. Blood-brain barrier transport of pramipexole, a dopamine D2 agonist.
Okura T; Ito R; Ishiguro N; Tamai I; Deguchi Y
Life Sci; 2007 Apr; 80(17):1564-71. PubMed ID: 17307202
[TBL] [Abstract][Full Text] [Related]
18. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
Boström E; Simonsson US; Hammarlund-Udenaes M
Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.
Suzuki T; Fukami T; Tomono K
Biopharm Drug Dispos; 2015 Mar; 36(2):126-37. PubMed ID: 25410756
[TBL] [Abstract][Full Text] [Related]
20. Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs.
André P; Debray M; Scherrmann JM; Cisternino S
J Cereb Blood Flow Metab; 2009 Jul; 29(7):1293-304. PubMed ID: 19458607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
